Editorial - Japanese Journal of Oncology

Editorial (partial view)

Following on from 2015, in which the Japanese Journal of Clinical Oncology’s Impact Factor rose above 2 for the first time and we received a record number of new submissions, 2016 was a relatively quiet year for the journal in terms of news to report.

Domestic and international submissions remained steady in almost all cases except for a significant decrease in submissions from China. Of course JJCO welcomes high-quality submissions from all countries around the world, but along with some excellent papers that we have been very proud to publish, the dramatically increasing number of submissions from China in recent years had unfortunately brought with it a large number of speculative submissions of papers that were clearly not within the scope of the journal, and this had been …